Atlas Trials

Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation

Clinical trial NCT05084586 · UNKNOWN

Trial details

NCT number
NCT05084586
Sponsor
Ankara Training and Research Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Bladder CancerEpirubicin Adverse ReactionSuperficial Bladder CancerTumor Recurrence
Start date
2019-10-01
Primary completion
2023-10-05
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.